Roth MKM Maintains Buy on BioRestorative Therapies, Raises Price Target to $18
Roth MKM Maintains Buy on BioRestorative Therapies, Raises Price Target to $18
Roth MKm維持對BioRestorative Therapies的買入評級,將目標價格上調至18美元。
Roth MKM analyst Jonathan Aschoff maintains BioRestorative Therapies (NASDAQ:BRTX) with a Buy and raises the price target from $15 to $18.
Roth MKm分析師Jonathan Aschoff繼續看好BioRestorative Therapies(NASDAQ:BRTX),並將價格目標從15美元上調至18美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。